Verdegard Com Ceo

https://en.wikipedia.org › wiki › Fingolimod
Fingolimod is a sphingosine 1 phosphate receptor modulator which sequesters lymphocytes in lymph nodes preventing them from contributing to an autoimmune reaction

https://www.drugs.com › mtm › fingolimod.html
Fingolimod is used in adults and children at least 10 years old to treat relapsing forms of multiple sclerosis including clinically isolated syndrome relapsing remitting disease and active

https://www.mssociety.org.uk › ... › disease-modifying-therapies › fingolimod
Fingolimod Gilenya works by targeting B and T cells These are special types of white blood cells in your immune system It s thought that these cells cause a lot of the damage in MS

https://www.medicines.org.uk › emc › product › pil
What Fingolimod is and what it is used for The active substance of Fingolimod Capsules is fingolimod MS is a long term condition that affects the central nervous system CNS comprised

https://www.mayoclinic.org › drugs-supplements › fingolimod-oral-route › ...
Fingolimod is used to treat the relapsing forms of multiple sclerosis MS including clinically isolated syndrome relapsing remitting disease and active secondary progressive disease

https://mstrust.org.uk › a-z › gilenya
Gilenya fingolimod is a disease modifying drug DMD for relapsing remitting MS You take Gilenya as a pill once a day to reduce the number and severity of relapses

https://www.webmd.com › drugs › fingolimod-gilenya
Overview Fingolimod Gilenya is used to treat multiple sclerosis It works by targeting a type of immune cell called lymphocytes reducing the frequency of multiple sclerosis relapses

https://www.gov.uk › drug-safety-update › fingolimod-gilenyav-updated...
Fingolimod Gilenya is authorised to treat patients aged 10 years or older with highly active relapsing remitting multiple sclerosis that has not responded to at least one disease modifying

https://patient-info.co.uk › patient-leaflet
How does Fingolimod affect my immune system Fingolimod works by keeping certain immune cells in lymph nodes reducing their ability to cause inflammation in the central nervous system